Mark R. Thompson, Vice President, Sales and Managed Markets

Mark R. Thompson has served as our Vice President, Sales and Managed Markets, since April 2008. From January 2006 to July 2007, Mr. Thompson served as Vice President, Sales of Valeant Pharmaceuticals International, where he led both the hepatology and neuroscience sales teams, as well as the management of sales operations, analytics and training. From March 2004 to December 2005, Mr. Thompson was the Vice President, Sales, at InterMune, Inc., and from October 2002 to March 2004, he was the Vice President, Sales, at SkinMedica, Inc. From August 2001 to October 2002, Mr. Thompson served as Senior Director, National Sales, at Elan Biopharmaceuticals, Inc., Primary Care Division, leading a sales team of approximately 500 people. From July 1980 to August 2001, Mr. Thompson held positions of increasing responsibility at GlaxoSmithKline Capital, serving most recently as Regional Vice President, where his responsibilities included sales of Imitrex^® and other CNS products. Mr. Thompson holds an M.Ed. in Administration and Supervision from the University of North Carolina–Chapel Hill.